Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 167 of 1,261
  1. US 11771748

    Methods for treating tumor-induced osteomalacia

    Ultragenyx Pharmaceutical Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  2. US 11773143

    Conformational epitopes in respiratory syncytial virus G protein central conserved region

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  3. US 11771680

    Pyrrole compounds

    Aligos Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  4. US 11771667

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  5. US 11773138

    Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

    Theradaptive, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  6. US 11773085

    Methods and compounds for treating disorders

    FOGHORN THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  7. US 11771751

    Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  8. US 11773103

    IRAK4 degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  9. US 11773057

    Naphthalenesulfonamide compound, preparation method, and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  10. US 11773119

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  11. US 11773185

    Anti-BACE1 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  12. US 11773148

    Tau peptide immunogen constructs

    UNITED NEUROSCIENCE · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  13. US 11771671

    Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction

    OVID THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  14. US 11771879

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  15. US 11773076

    Crystalline forms of a somatostatin modulator

    CRINETICS PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  16. US 11771752

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Prime Bio, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  17. US 11773393

    Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  18. US 11771776

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  19. US 11773083

    Solid state forms of Belumosudil and Belumosudil salts

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  20. US 11771762

    Anti-ErbB3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  21. US 11771745

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  22. US 2023302008

    METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted
  23. WO 2023183767

    MÉTHODES ET COMPOSITIONS POUR AUGMENTER LA SENSIBILITÉ À L'INSULINE

    ABBOTT LAB [US] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted
  24. US 11767355

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.